{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:23:48Z","timestamp":1794605028059,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007489","name":"Bausch and Lomb Rochester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ajo.2023.03.008","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T07:16:54Z","timestamp":1679383014000},"page":"265-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study"],"prefix":"10.1016","volume":"252","author":[{"given":"John D.","family":"Sheppard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice T.","family":"Epitropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-2076","authenticated-orcid":false,"given":"Sonja","family":"Kr\u00f6sser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Vittitow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2023.03.008_bib0001","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2023.03.008_bib0002","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","article-title":"Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older","volume":"182","author":"Farrand","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.008_bib0003","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2023.03.008_bib0004","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2147\/OPTH.S89700","article-title":"Associations between signs and symptoms of dry eye disease: a systematic review","volume":"9","author":"Bartlett","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.008_bib0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtos.2015.11.002","article-title":"Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review","volume":"14","author":"McDonald","year":"2016","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.008_bib0006","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2023.03.008_bib0007","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","article-title":"Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.ajo.2023.03.008_bib0008","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1167\/iovs.09-4445","article-title":"Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore","volume":"51","author":"Tong","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2023.03.008_bib0009","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1111\/aos.13732","article-title":"The prevalence of meibomian gland dysfunction, tear film and ocular surface parameters in an Austrian dry eye clinic population","volume":"96","author":"Rabensteiner","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.008_bib0010","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The International Workshop on Meibomian Gland Dysfunction: report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian Gland","volume":"52","author":"Knop","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.008_bib0011","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.008_bib0012","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1194\/jlr.M044826","article-title":"Extensive characterization of human tear fluid collected using different techniques unravels the presence of novel lipid amphiphiles","volume":"55","author":"Lam","year":"2014","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.008_bib0013","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2023.03.008_bib0014","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/ijms18071398","article-title":"Dry eye management: targeting the ocular surface microenvironment","volume":"18","author":"Zhang","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.008_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICL.0000000000000680","article-title":"A review on evidence-based treatments for meibomian gland dysfunction","volume":"46","author":"Lam","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"6","key":"10.1016\/j.ajo.2023.03.008_bib0016","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/cxo.13035","article-title":"Non-pharmaceutical treatment options for meibomian gland dysfunction","volume":"103","author":"Arita","year":"2020","journal-title":"Clin Exp Optom"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.008_bib0017","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jtos.2017.01.006","article-title":"Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: proceedings of the OCEAN group meeting","volume":"15","author":"Geerling","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.008_bib0018","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jtos.2019.02.012","article-title":"Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: a systematic literature review","volume":"17","author":"Holland","year":"2019","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.008_bib0019","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2021.11.004","article-title":"Efficacy and safety of OC-01 (varenicline solution) nasal spray on signs and symptoms of dry eye disease: the ONSET-2 phase 3, randomized trial","volume":"129","author":"Wirta","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2023.03.008_bib0020","series-title":"Oyster Point Pharma, Inc","author":"Tyrvaya nasal spray [package insert]","year":"2021"},{"issue":"1\u20132","key":"10.1016\/j.ajo.2023.03.008_bib0021","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2018.01.019","article-title":"Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs","volume":"538","author":"Agarwal","year":"2018","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.008_bib0022","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/jop.2019.0092","article-title":"Influence of perfluorohexyloctane eye drops on tear film thickness in patients with mild to moderate dry eye disease: a randomized controlled clinical trial","volume":"36","author":"Schmidl","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.008_bib0023","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jtos.2019.02.010","article-title":"Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics","volume":"17","author":"Agarwal","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2023.03.008_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2023.100704","article-title":"In vitro inhibition of evaporation with perfluorohexyloctane, an eye drop for dry eye disease [published online ahead of print May 23, 2023]","author":"Vittitow","year":"2023","journal-title":"Curr Ther Res"},{"issue":"9","key":"10.1016\/j.ajo.2023.03.008_bib0025","first-page":"2656","article-title":"Ocular and systemic distribution of 14C- perfluorohexyloctane following topical ocular administration to rabbits [abstract]","volume":"59","author":"Kr\u00f6sser","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2023.03.008_bib0026","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/ICO.0000000000002622","article-title":"A randomized clinical study (SEECASE) to assess efficacy, safety, and tolerability of NOV03 for treatment of dry eye disease","volume":"40","author":"Tauber","year":"2021","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2023.03.008_bib0027","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ophtha.2022.12.021","article-title":"on behalf of the GOBI Study Group. NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI study","volume":"130","author":"Tauber","year":"2023","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.008_bib0028","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","article-title":"Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting","volume":"11","author":"Baudouin","year":"2013","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.ajo.2023.03.008_bib0029","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/ICO.0b013e318180e55c","article-title":"Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study","volume":"27","author":"Troiano","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2023.03.008_bib0030","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/bjo.86.8.879","article-title":"Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sj\u00f6gren's syndrome in patients","volume":"86","author":"Aragona","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.008_bib0031","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s40123-022-00516-9","article-title":"Selective pharmacologic therapies for dry eye disease treatment: efficacy, tolerability, and safety data review from preclinical studies and pivotal trials","volume":"11","author":"Shen Lee","year":"2022","journal-title":"Ophthalmol Ther"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:44:29Z","timestamp":1762080269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":31,"alternative-id":["S0002939423000983"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.03.008","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}